John Zhang to Protein Kinase Inhibitors
This is a "connection" page, showing publications John Zhang has written about Protein Kinase Inhibitors.
Connection Strength
0.361
-
Fan R, Enkhjargal B, Camara R, Yan F, Gong L, Tang J, Chen Y, Zhang JH. Critical role of EphA4 in early brain injury after subarachnoid hemorrhage in rat. Exp Neurol. 2017 10; 296:41-48.
Score: 0.142
-
Yin C, Huang GF, Sun XC, Guo Z, Zhang JH. Tozasertib attenuates neuronal apoptosis via DLK/JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats. Neuropharmacology. 2016 09; 108:316-23.
Score: 0.130
-
Yang P, Manaenko A, Xu F, Miao L, Wang G, Hu X, Guo ZN, Hu Q, Hartman RE, Pearce WJ, Obenaus A, Zhang JH, Chen G, Tang J. Role of PDGF-D and PDGFR-? in neuroinflammation in experimental ICH mice model. Exp Neurol. 2016 09; 283(Pt A):157-64.
Score: 0.033
-
Iniaghe LO, Krafft PR, Klebe DW, Omogbai EKI, Zhang JH, Tang J. Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage. Neurobiol Dis. 2015 Oct; 82:349-358.
Score: 0.031
-
Wang T, Wu X, Yin C, Klebe D, Zhang JH, Qin X. CRMP-2 is involved in axon growth inhibition induced by RGMa in vitro and in vivo. Mol Neurobiol. 2013 Jun; 47(3):903-13.
Score: 0.026